ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 115 filers reported holding ENZO BIOCHEM INC in Q3 2017. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $41,000 | -59.4% | 11,807 | -70.6% | 0.01% | -58.8% |
Q4 2020 | $101,000 | -28.4% | 40,172 | -39.7% | 0.02% | -29.2% |
Q3 2020 | $141,000 | +354.8% | 66,672 | +379.3% | 0.02% | +41.2% |
Q2 2020 | $31,000 | -32.6% | 13,911 | -20.9% | 0.02% | +240.0% |
Q4 2019 | $46,000 | -63.2% | 17,593 | -49.4% | 0.01% | -70.6% |
Q3 2019 | $125,000 | -51.2% | 34,793 | -54.2% | 0.02% | -41.4% |
Q2 2019 | $256,000 | +52.4% | 75,900 | +23.2% | 0.03% | +70.6% |
Q1 2019 | $168,000 | -1.8% | 61,600 | -0.1% | 0.02% | -15.0% |
Q4 2018 | $171,000 | -32.7% | 61,657 | 0.0% | 0.02% | +42.9% |
Q3 2018 | $254,000 | -53.7% | 61,657 | -41.7% | 0.01% | -48.1% |
Q2 2018 | $549,000 | -30.2% | 105,700 | -26.3% | 0.03% | -35.7% |
Q1 2018 | $786,000 | -31.5% | 143,400 | +1.9% | 0.04% | -40.0% |
Q4 2017 | $1,147,000 | -24.0% | 140,700 | -2.4% | 0.07% | -32.0% |
Q3 2017 | $1,509,000 | -20.4% | 144,091 | -16.1% | 0.10% | -16.9% |
Q2 2017 | $1,895,000 | -28.6% | 171,691 | -45.8% | 0.12% | -12.7% |
Q1 2017 | $2,653,000 | +45.3% | 316,931 | +20.5% | 0.14% | +30.3% |
Q4 2016 | $1,826,000 | +124.6% | 263,100 | +64.6% | 0.11% | +147.7% |
Q3 2016 | $813,000 | +30.3% | 159,808 | +52.9% | 0.04% | +29.4% |
Q2 2016 | $624,000 | -25.4% | 104,508 | -43.2% | 0.03% | -35.8% |
Q1 2016 | $837,000 | -28.3% | 184,027 | -29.1% | 0.05% | -7.0% |
Q4 2015 | $1,168,000 | +33.5% | 259,527 | -6.0% | 0.06% | +32.6% |
Q3 2015 | $875,000 | +17.9% | 276,098 | +12.7% | 0.04% | +53.6% |
Q2 2015 | $742,000 | +137.1% | 244,894 | +130.8% | 0.03% | +133.3% |
Q1 2015 | $313,000 | -6.3% | 106,096 | +41.0% | 0.01% | -47.8% |
Q4 2014 | $334,000 | +384.1% | 75,226 | +463.7% | 0.02% | +475.0% |
Q3 2014 | $69,000 | -61.5% | 13,345 | -60.9% | 0.00% | -50.0% |
Q2 2014 | $179,000 | -3.2% | 34,093 | -46.2% | 0.01% | -46.7% |
Q4 2013 | $185,000 | +6.9% | 63,393 | -7.4% | 0.02% | +7.1% |
Q3 2013 | $173,000 | +15.3% | 68,493 | -5.1% | 0.01% | -22.2% |
Q2 2013 | $150,000 | – | 72,193 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
Corsair Capital Management | 58,657 | $188,000 | 0.04% |
BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |